Evaluation of creatine kinase (CK)-MB to total CK ratio as a diagnostic biomarker for primary tumors and metastasis screening
Open Access
- 15 September 2023
- journal article
- research article
- Published by Elsevier in Practical Laboratory Medicine
- Vol. 37, e00336
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Shandong Province (202019129, ZR2022QH078)
This publication has 37 references indexed in Scilit:
- Clinically effective CK-MB reportingJournal of Postgraduate Medicine, 2010
- Clinical role of recurrently elevated macro creatine kinase type 1Journal of Clinical Laboratory Analysis, 2008
- Macro-creatincinasa: marcador de enfermedad. Guía práctica para su manejoAnales de Medicina Interna, 2006
- Mitochondrial creatine kinase in human health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- Consensus of DGKL and VDGH for interim reference intervals on enzymes in serum Konsensus von DGKL und VDGH zu vorläufigen Referenzbereichen für SerumenzymeJournal of Laboratory Medicine, 2005
- Falsch hohe CK-MB Aktivitätsmessung nach Kryoablation der Prostata ohne MyokardinfarktAINS - Anästhesiologie · Intensivmedizin · Notfallmedizin · Schmerztherapie, 1997
- Quantification of creatine kinase BB isoenzyme in tumor cytosols and serum with an ultrasensitive time-resolved immunofluorometric techniqueClinical Biochemistry, 1995
- Macro creatine kinase type 2 in a patient with prostatic carcinomaClinica Chimica Acta, 1991
- Serum CK-BB as a tumor marker in patients with carcinoma confirmed histologicallyClinica Chimica Acta, 1989
- Release patterns of CK-MB and mitochondrial CK following myocardial ischaemiaClinica Chimica Acta, 1985